Committee approves bill to remove cost sharing for clinically‑appropriate genetic tests and related screening
Senators advanced House Bill 1079 to require insurers to eliminate cost sharing for clinically appropriate genetic tests and follow‑up screening; sponsor and survivors said earlier detection and tailored treatment could save lives and control downstream costs.
The full story
The Senate Insurance & Commerce Committee approved House Bill 1079, which would require insurers to cover clinically appropriate genetic tests and the follow‑up screenings those tests recommend without cost sharing when medically appropriate, supporters said.
Sign up to keep reading.
Your free newsletter brings you what your city council, county, and school board discussed and decided.
or